MVIS.NASDAQMicrovision, INC

Form 4: MicroVision Director Simon Biddiscombe Reports Stock Award Vesting

Sentiment:

SEC Form 4 Filing


Director Simon Biddiscombe reports the vesting of restricted stock units (RSUs) into common stock of MicroVision, Inc.

Summary

  • On March 3, 2025, Simon Biddiscombe, a director of MicroVision, Inc., reported the vesting of 20,112 restricted stock units (RSUs) into common stock.
  • These RSUs converted into shares on a one-to-one basis without any payment required.
  • Following this transaction, Biddiscombe directly owns 205,166 shares of MicroVision common stock.
  • The RSUs were granted on June 5, 2024, and vest in equal quarterly installments until the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continued service as a director.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure of stock vesting, neither particularly positive nor negative.

Positives

  • The vesting of RSUs indicates continued alignment of the director's interests with those of the shareholders.

Industry Context

This is a standard SEC Form 4 filing, common for corporate insiders reporting changes in their beneficial ownership of company stock. It reflects part of the company's compensation strategy.

Stakeholder Impact

  • The vesting of RSUs has a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
06/05/2024Date the Restricted Stock Units (RSUs) were granted.
03/03/2025Date of the reported transaction where RSUs vested and converted into common stock.
03/04/2025Date of the report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.